LPL Financial
OVID icon

LPL Financial’s Ovid Therapeutics OVID Stock Holding History

LPL Financial’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Sell
50,100
-19,448
-28% -$50.2K ﹤0.01% 5860
2026
Q1 		$154K Buy
69,548
+39,548
+132% +$70.7K ﹤0.01% 5580
2025
Q4 		$48.9K Buy
30,000
+18,000
+150% +$27.7K ﹤0.01% 5702
2025
Q3 		$15.6K Buy
+12,000
New +$10.4K ﹤0.01% 5753

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

LPL Financial's OVID Position: Q2 2026 in Review

LPL Financial reduced its Ovid Therapeutics (OVID) stake by 28% in Q2 2026, selling an estimated $50.2K and leaving 50,100 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #5860.

LPL Financial first reported a position in OVID in Q3 2025 and has held it in 4 quarters since. The position peaked at $154K in Q1 2026. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • LPL Financial held 50,100 shares of Ovid Therapeutics worth $135K as of Q2 2026.
  • LPL Financial sold 19,448 Ovid Therapeutics shares in Q2 2026, an estimated $50.2K.
  • Ovid Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5860 holding.
  • LPL Financial first reported a position in Ovid Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • LPL Financial's Ovid Therapeutics position peaked at $154K in Q1 2026.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.